Your inquiries are important to us, and our dedicated team is here to provide you with professional assistance.
Almeda Pharmaceuticals AG, a Swiss pharmaceutical company, and Callion Pharma, a company located in the USA, proudly announce their exclusive partnership for the Commonwealth of Independent States (CIS) region.
This collaboration aims to address the unique healthcare needs of rare disease patients in the region.
Key Points:
Exclusive Distribution: Almeda Pharmaceuticals AG becomes the exclusive distributor of Callion Pharma’s innovative rare disease therapies in the CIS region.
Rare Disease Focus: The collaboration prioritises the introduction of essential medications to benefit Cystic Fibrosis patients in CIS countries.
Patient-Centric Mission: Almeda Pharmaceuticals AG and Callion Pharma share a commitment to improving outcomes for Cystic Fibrosis patients through this strategic alliance.
Callion Pharma, CIS, Exclusive Partnership